It will be of potential clinical interest to see if exercise-induced mitochondrial-targeted p53 might represent a therapeutic intervention for aging-associated pathologies such as insulin resistance, diabetes, and cardiovascular diseases, which manifest telomere shortening in conjunction with mitochondrial dysfunction [40, 41]. Here, TP53 is linked to cardiovascular disorder.